Intrinsic Value

Alzamend Neuro, Inc. (ALZN)

$1

-0.04 (-3.85%)

Enterprise Value -
Net Debt -5.14
Equity Value -
Shares Outstanding 6.50
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt